180
I. Yavari et al.
C
ortho), 163.1 (C=O), 164.2 (C=O), 168.8 (d,
Diethyl (E)-2-((5Z)-5-benzylidene-2,5-dihydro-
2-oxothiazol-4-yl)butenedioate (7b, C18H17NO5S)
2JPC = 14.2 Hz, PC=C), 172.2 (C=O) ppm.
Yellow crystals; m.p.: 98–100 °C; yield 0.52 g (73%); IR
General procedure for the preparation of compounds
4 and 7
(KBr):
ꢀm = 1,676 (C=O), 1,735 (C=O), 1,424 (C=C) cm-1
;
EI-MS: m/z = 359 (M?, 6), 294 (38), 269 (17), 161 (15),
134 (100), 98 (11), 90 (27), 77 (29), 69 (40), 57 (24), 43
(67); 1H NMR (CDCl3): d = 1.28 (3H, t, 3J = 7.1 Hz,
Me), 1.38 (3H, t, 3J = 7.1 Hz, Me), 4.23 (2H, q,
To a stirred solution of the thiazolidine-2,4-dione (2 or 5,
2 mmol) and dialkyl acetylenedicarboxylate (1, 2 mmol) in
10 cm3 toluene was added dropwise a solution of 0.52 g
Ph3P (2 mmol) in 5 cm3 toluene at r.t. over 10 min. After
1 h stirring at r.t., the reaction mixture was refluxed. After
completion of the reaction [1–4 h, thin-layer chromatog-
raphy (TLC): AcOEt/hexane 2:1], the solvent was removed
from reaction mixture at reduced pressure and the residue
was purified by column chromatography [silica gel
230–240 mesh (Merck), hexane/AcOEt 4:1].
3
3J = 7.1 Hz, CH2O), 4.35 (2H, q, J = 7.1 Hz, CH2O),
7.23 (1H, s, CH), 7.46–7.58 (5H, m, CH), 7.95 (1H, s,
CH) ppm; 13C NMR (CDCl3): d = 14.3 (Me), 14.4 (Me),
62.2 (CH2O), 63.4 (CH2O), 121.4 (CH), 121.8 (CH), 130.4
(2CH), 130.8 (2CH), 132.8 (CH), 133.5 (C), 135.3 (C),
143.5 (C), 161.3, 162.6, 170.3 (3C=O), 170.6 (C=N) ppm.
Dimethyl (E)-2-((5Z)-5-(4-methylbenzylidene)-
2,5-dihydro-2-oxothiazol-4-yl)butenedioate
(7c, C17H15NO5S)
Dimethyl (E)-2-(2,5-dihydro-2-oxothiazol-4-yl)-
butenedioate (4a, C9H9NO5S)
Colorless crystals; m.p.: 109–111 °C; yield 0.52 g (74%);
ꢀ
IR (KBr): m = 1,681 (C=O), 1,749 (C=O), 1,429
Yellow crystals; m.p.: 107–109 °C; yield 0.34 g (67%); IR
(C=C) cm-1; EI-MS: m/z = 345 (M?, 7), 267 (22), 241
(34), 227 (11), 176 (12), 148 (100), 104 (24), 91 (34), 84
-1
ꢀ
(KBr): m = 1,693 (C=O), 1,741 (C=O), 1,436 (C=C) cm
;
EI-MS: m/z = 243 (M?, 10), 125 (14), 77 (25), 74 (10), 69
(42), 57 (33), 43 (100); 1H NMR (CDCl3): d = 3.80 (3H, s,
MeO), 3.89 (3H, s, MeO), 4.14 (2H, s, CH2S), 7.20 (1H, s,
CH) ppm; 13C NMR (CDCl3): d = 35.9 (CH2S), 53.1
(MeO), 54.0 (MeO), 132.1 (C), 143.4 (CH), 161.3, 162.6,
170.1 (3C=O), 170.4 (C=N) ppm.
1
(8), 77 (19), 69 (30), 57 (28), 43 (65); H NMR (CDCl3):
d = 2.38 (3H, s, Me), 3.79 (3H, s, Me), 3.90 (3H, s, Me),
7.24 (1H, s, CH), 7.31 (2H, d, J = 7.5 Hz, 2CH), 7.44
3
3
(2H, d, J = 7.5 Hz, 2CH), 7.93 (1H, s, CH) ppm; 13C
NMR (CDCl3): d = 22.0 (Me), 53.1 (MeO), 54.0 (MeO),
121.6 (CH), 129.9 (CH), 130.8 (2CH), 130.9 (2CH), 131.5
(C), 133.3 (C), 133.5 (C), 135.3 (C), 161.3, 162.8, 170.2
(3C=O), 170.6 (C=N) ppm.
Diethyl (E)-2-(2,5-dihydro-2-oxothiazol-4-yl)butenedioate
(4b, C11H13NO5S)
Yellow crystals; m.p.: 108–111 °C; yield 0.36 g (65%); IR
Diethyl (E)-2-((5Z)-5-(4-methylbenzylidene)-2,5-dihydro-
2-oxothiazol-4-yl)butenedioate (7d, C19H19NO5S)
-1
;
ꢀ
(KBr) m = 1,691 (C=O), 1,739 (C=O), 1,435 (C=C) cm
EI-MS: m/z = 271 (M?, 8), 125 (15), 77 (27), 74 (11), 69
(45), 57 (36), 43 (100); 1H NMR (CDCl3): d = 1.30 (3H, t,
3J = 7.1 Hz, Me), 1.35 (3H, t, 3J = 7.1 Hz, Me), 4.14 (2H,
Colorless crystals; m.p.: 110–112 °C; yield 0.54 g (72%);
ꢀ
IR (KBr): m = 1,671 (C=O), 1,737 (C=O), 1,428
(C=C) cm-1; EI-MS: m/z = 373 (M?, 10), 294 (26), 269
(38), 227 (13), 176 (15), 148 (100), 104 (21), 98 (10), 91
(35), 77 (18), 69 (35), 57 (31), 43 (60); 1H NMR (CDCl3):
d = 1.28 (3H, t, 3J = 7.1 Hz, Me), 1.33 (3H, t,
3J = 7.1 Hz, Me), 2.43 (3H, s, Me), 4.23 (2H, q,
3
s, CH2S), 4.27 (2H, q, J = 7.1 Hz, CH2O), 4.33 (2H, q,
3J = 7.1 Hz, CH2O), 7.05 (1H, s, CH) ppm; 13C NMR
(CDCl3): d = 14.3 (Me), 14.4 (Me), 35.9 (CH2S), 62.2
(CH2O), 63.4 (CH2O), 132.0 (C), 143.3 (CH), 161.2, 162.6,
170.1, (3C=O), 170.3 (C=N) ppm.
3
3J = 7.1 Hz, CH2O), 4.33 (2H, q, J = 7.1 Hz, CH2O),
3
7.23 (1H, s, CH), 7.31 (2H, d, J = 7.5 Hz, 2CH), 7.44
Dimethyl (E)-2-((5Z)-5-benzylidene-2,5-dihydro-
2-oxothiazol-4-yl)butenedioate (7a, C16H13NO5S)
3
(2H, d, J = 7.5 Hz, 2CH), 7.93 (1H, s, CH) ppm; 13C
NMR (CDCl3): d = 14.3 (Me), 14.4 (Me), 22.0 (Me), 62.3
(CH2O), 63.4 (CH2O), 121.6 (CH), 129.9 (CH), 130.8
(2CH), 130.9 (2CH), 131.5 (C), 133.3 (C), 133.5 (C), 135.3
(C), 161.3, 162.8, 170.2 (3C=O), 170.6 (C=N) ppm.
Yellow crystals; m.p.: 99–101 °C; yield 0.44 g (64%); IR
-1
ꢀ
(KBr): m = 1,628 (C=O), 1,749 (C=O), 1,424 (C=C) cm
;
EI-MS: m/z = 331 (M?, 7), 267 (24), 241 (33), 227 (15), 161
(16), 134 (100), 90 (23), 84 (9), 77 (21), 69 (33), 57 (20), 43
(61); 1H NMR (CDCl3): d = 3.80 (3H, s, MeO), 3.91 (3H, s,
MeO), 7.25 (1H, s, CH), 7.47–7.58 (5H, m, 5 CH), 7.95 (1H,
s, CH) ppm; 13C NMR (CDCl3): d = 53.3 (MeO), 54.0
(MeO), 121.4 (CH), 129.7 (CH), 130.7 (2CH), 130.9 (2CH),
131.2 (C), 133.1 (CH), 133.4 (C), 135.3 (C), 161.3, 162.7,
170.2 (3C=O), 170.6 (C=N) ppm.
Dimethyl (E)-2-((5Z)-5-(thiophen-2-ylmethylene)-2,5-
dihydro-2-oxothiazol-4-yl)butenedioate
(7e, C14H11NO5S2)
Yellow crystals; m.p.: 87–89 °C; yield 0.46 g (70%); IR
-1
ꢀ
(KBr): m = 1,689 (C=O), 1,735 (C=O), 1,431 (C=C) cm
;
EI-MS: m/z = 337 (M?, 5), 241 (36), 219 (17), 167 (16),
123